Julien Bradley

Julien has been the CEO of RedShiftBio since late 2019 when he was brought on to help accelerate commercial growth directly following the launch of the company’s MMS technology. Prior to RedShiftBio, Julien held executive and leadership roles over 15 years at Quanterix, ThermoFisher Scientific, Ahura Scientific, and Boston Scientific.  He holds a B.S. From Amherst College and an MBA from the Tuck School of Business at Dartmouth.